Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Ampliphi Biosciences Corp.
Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 2013 5-year trend
Sales/Revenue 9.86M 10.33M 8.72M 12.17M 325,000
Cost of Goods Sold (COGS) incl. D&A 14.48M 17.71M 15.18M - 82,000
COGS excluding D&A 13.76M 17.11M 14.67M - 0
Depreciation & Amortization Expense 720,000 602,000 516,000 - 82,000
Depreciation 720,000 602,000 516,000 - 82,000
Amortization of Intangibles 0 0 0 - 0
Gross Income (4.62M) (7.38M) (6.47M) - 243,000
2006 2007 2008 2009 2013 5-year trend
SG&A Expense 6.38M 7.03M 5.82M - 12.68M
Research & Development - - - - 6.5M
Other SG&A 6.38M 7.03M 5.82M - 6.18M
Other Operating Expense 0 0 0 - 0
Unusual Expense 23.15M 2.15M 8.8M - 40.56M
EBIT after Unusual Expense (23.15M) (2.15M) (8.8M) - (40.56M)
Non Operating Income/Expense 0 0 91,000 6.26M 0
Non-Operating Interest Income 567,000 428,000 279,000 - 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 411,000 1,000 - - 2.86M
Gross Interest Expense 411,000 1,000 - - 2.86M
Interest Capitalized - - - - 0
Pretax Income (33.99M) (16.13M) (20.72M) 7.95M (55.86M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 - 0
Consolidated Net Income (33.99M) (16.13M) (20.72M) 7.95M (55.86M)
Minority Interest Expense - - - - 0
Net Income (33.99M) (16.13M) (20.72M) 7.95M (55.86M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - - 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (33.99M) (16.13M) (20.72M) 7.95M (55.86M)
Preferred Dividends 0 0 0 0 8.46M
Net Income Available to Common (33.99M) (16.13M) (20.72M) 7.95M (64.33M)
EPS (Basic) (3.47) (0.98) (1.04) 0.39 (0.64)
Basic Shares Outstanding 9.79M 16.5M 19.95M 20.56M 101.2M
EPS (Diluted) (3.47) (0.98) (1.04) 0.39 (0.64)
Diluted Shares Outstanding 9.79M 16.5M 19.95M 20.56M 101.2M
EBITDA (10.28M) (13.8M) (11.77M) - (12.35M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.